Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales

Background: Experience in real clinical practice with ceftazidime-avibactam for the treatment of serious infections due to gram−negative bacteria (GNB) other than carbapenem-resistant Enterobacterales (CRE) is very limited. Methods: We carried out a retrospective multicenter study of patients hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Vena, Antonio, Giacobbe, Daniele Roberto, Castaldo, Nadia, Cattelan, Annamaria, Mussini, Cristina, Luzzati, Roberto, De Rosa, Francesco Giuseppe, Puente, Filippo Del, Mastroianni, Claudio Maria, Cascio, Antonio, Carbonara, Sergio, Capone, Alessandro, Boni, Silvia, Sepulcri, Chiara, Meschiari, Marianna, Raumer, Francesca, Oliva, Alessandra, Corcione, Silvia, Bassetti, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168189/
https://www.ncbi.nlm.nih.gov/pubmed/32050434
http://dx.doi.org/10.3390/antibiotics9020071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168189/
https://www.ncbi.nlm.nih.gov/pubmed/32050434
http://dx.doi.org/10.3390/antibiotics9020071

Ejemplares similares